Health
Pfizer Goes It Alone to Expand Vaccine Business Beyond Covid-19 Pandemic – The Wall Street Journal
CEO Albert Bourla says company will use gene-based technology learned by working with Germany’s BioNTech to tackle other diseases
Pfizer Inc. aims to expand its vaccine business by becoming a leader in the new gene-based technology behind its successful Covid-19 shots.
Pfizer will develop new shots using the technology, called mRNA, to target other viruses and pathogens beyond the coronavirus, Chief Executive Albert Bourla said in an interview. He said the companys scientists and engineers gained a decades worth of experience in the past year working on the Covid-19 vaccine with Germanys BioNTech SE , and is ready to pursue…
-
Noosa News20 hours agoHow Lily Steele-Park took her rapist to court and won
-
Business22 hours ago5 things to watch on the ASX 200 on Tuesday 8 July 2025
-
Noosa News20 hours agoE-biker charged with riding dangerously, assaulting cop
-
Noosa News23 hours agoStar’s Brisbane casino has been in the headlines for months: What’s the latest?